logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Andrea Gallamini

centre antoine-lacassagne
H指数:64
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial)

老年霍奇金淋巴瘤一线治疗中使用 Brentuximab Vedotin 和 Bendamustine 的长期结果（HALO试验）

British Journal of Haematology
IF3.8
2026-09-060
OAAI
Andrea Gallamini; Simonetta Viviani; Davide Rapezzi; Caterina Patti; Pierre Feugier; Alessandro Rambaldi; Fontanet Bijou; Anna Borra; Cécile Borel; Tanguy Pace-Loscos; Renaud Schiappa; Stephane Chauvie; Colin Debaigt; Anna Guidetti; Olivier Humbert; Jean-Marc Schiano De Colella
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol

无放射治疗对低代谢肿瘤体积和2个化疗周期后中期PET阴性定义的良好预后早期非巨大肿块霍奇金淋巴瘤初始治疗的RAFTING试验方案

Biomedicines
IF3.9
2026-08-290
OA
Kateryna Filonenko; Marco Picardi; Stephane Chauvie; Andrea Riccardo Filippi; Maria Cristina Pirosa; Luca Guerra; Federico Fallanca; Marta Bednarek; Michał Kurlapski; Eva Domingo-Domenech; Andrea Visentin; Caterina Patti; Ramón García-Sanz; Javier Nunez; Javier Lopez-Jiménez; Agnieszka Giza; Adam Wyszomirski; Alessandro Rambaldi; Davide Rossi; Anna Sureda; Andrea Gallamini; Jan Maciej Zaucha
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials

III期经典霍奇金淋巴瘤患者在接受2个ABVD疗程后，中期PET（PET-2）德瓦伊评分5分的患者：三项多中心试验的合并分析

Blood Cancer Journal
IF11.6
2025-10-160
OA
Simonetta Viviani; Chiara Pavoni; Sally F. Barrington; Luca Guerra; Heiko Schöder; Peter Johnson; Amy A. Kirkwood; Deborah M. Stephens; Jonathan W. Friedberg; Stephane Chauvie; Michael V. Knopp; Stefano Luminari; Daniel Molin; Paolo Corradini; Andrea Gallamini; Alessandro Rambaldi; Corrado Tarella
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial

HD0607临床试验中治疗结束时FDG PET/CT对进展期霍奇金淋巴瘤治疗结局的预测价值

HEMATOLOGICAL ONCOLOGY
IF3.9
2023-01-041
OA
Biggi, Alberto; Chauvie, Stephane; Fallanca, Federico; Guerra, Luca; Bergesio, Fabrizio; Menga, Massimo; Bianchi, Andrea; Gregianin, Michele; Chiaravalloti, Agostino; Schillaci, Orazio; Pavoni, Chiara; Patti, Caterina; Picardi, Marco; Romano, Alessandra; Schiavotto, Corrado; Sorasio, Roberto; Viviani, Simonetta; La Nasa, Giorgio; Trentin, Livio; Rambaldi, Alessandro; Gallamini, Andrea
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma

Brentuximab Vedotin在III期或IV期霍奇金淋巴瘤中的总体生存率

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2022-07-28158
OA
Ansell, Stephen M.; Radford, John; Connors, Joseph M.; Dlugosz-Danecka, Monika; Kim, Won-Seog; Gallamini, Andrea; Ramchandren, Radhakrishnan; Friedberg, Jonathan W.; Advani, Ranjana; Hutchings, Martin; Evens, Andrew M.; Smolewski, Piotr; Savage, Kerry J.; Bartlett, Nancy L.; Eom, Hyeon-Seok; Abramson, Jeremy S.; Dong, Cassie; Campana, Frank; Fenton, Keenan; Puhlmann, Markus; Straus, David J.
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi
ANNALS OF HEMATOLOGY
IF2.4
2021-07-302
PREAI
Santoro, Armando; Mazza, Rita; Spina, Michele; Califano, Catello; Specchia, Giorgina; Carella, Michele; Consoli, Ugo; Palombi, Francesca; Musso, Maurizio; Pulsoni, Alessandro; Kovalchuk, Sofya; Bonfichi, Maurizio; Ricci, Francesca; Fabbri, Alberto; Liberati, Anna Marina; Rodari, Marcello; Giordano, Laura; Chimienti, Emanuela; Balzarotti, Monica; Sorasio, Roberto; Gallamini, Andrea; Ghiggi, Chiara; Ciammella, Patrizia; Ricardi, Umberto; Chauvie, Stephane; Carlo-Stella, Carmelo; Merli, Francesco
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study

先前未经治疗的晚期经典霍奇金淋巴瘤的老年患者 (年龄 ≥ 60岁): 来自III期ECHELON-1研究的详细分析

HAEMATOLOGICA
IF7.9
2021-06-2440
OAAI
Evens, Andrew M.; Connors, Joseph M.; Younes, Anas; Ansell, Stephen M.; Kim, Won Seog; Radford, John; Feldman, Tatyana; Tuscano, Joseph; Savage, Kerry J.; Oki, Yasuhiro; Grigg, Andrew; Pocock, Christopher; Dlugosz-Danecka, Monika; Fenton, Keenan; Forero-Torres, Andres; Liu, Rachael; Jolin, Hina; Gautam, Ashish; Gallamini, Andrea
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Brentuximab vedotin联合化疗治疗III期或IV期经典霍奇金淋巴瘤 (ECHELON-1): 一项国际、开放标签、随机、3期试验的5年更新

LANCET HAEMATOLOGY
IF17.7
2021-06-0198
PRE
Straus, David J.; Dlugosz-Danecka, Monika; Connors, Joseph M.; Alekseev, Sergey; Illes, Arpad; Picardi, Marco; Lech-Maranda, Ewa; Feldman, Tatyana; Smolewski, Piotr; Savage, Kerry J.; Bartlett, Nancy L.; Walewski, Jan; Ramchandren, Radhakrishnan; Zinzani, Pier Luigi; Hutchings, Martin; Munoz, Javier; Lee, Hun Ju; Kim, Won Seog; Advani, Ranjana; Ansell, Stephen M.; Younes, Anas; Gallamini, Andrea; Liu, Rachael; Little, Meredith; Fenton, Keenan; Fanale, Michelle; Radford, John
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study
HEMATOLOGICAL ONCOLOGY
IF3.9
2021-02-1615
OAAI
Hutchings, Martin; Radford, John; Ansell, Stephen M.; Illes, Arpad; Sureda, Anna; Connors, Joseph M.; Sykorova, Alice; Shibayama, Hirohiko; Abramson, Jeremy S.; Chua, Neil S.; Friedberg, Jonathan W.; Koren, Jan; LaCasce, Ann Steward; Molina, Lysiane; Engley, Gerald; Fenton, Keenan; Jolin, Hina; Liu, Rachael; Gautam, Ashish; Gallamini, Andrea
Early serumTARCreduction predicts prognosis in advanced-stageHodgkinlymphoma patients treated with aPET-adapted strategy
HEMATOLOGICAL ONCOLOGY
IF3.9
2020-07-3010
PREAI
Viviani, Simonetta; Mazzocchi, Arabella; Pavoni, Chiara; Taverna, Francesca; Rossi, Andrea; Patti, Caterina; Romano, Alessandra; Trentin, Livio; Sorasio, Roberto; Guidetti, Anna; Gottardi, Daniela; Tarella, Corrado; Cimminiello, Michele; Zanotti, Roberta; Farina, Lucia; Ferreri, Andres Jose Maria; Galbiati, Marina; Corradini, Paolo; Gianni, Alessandro Massimo; Gallamini, Andrea; Rambaldi, Alessandro
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2018-01-25564
OAAI
Connors, J. M.; Jurczak, W.; Straus, D. J.; Ansell, S. M.; Kim, W. S.; Gallamini, A.; Younes, A.; Alekseev, S.; Illes, A.; Picardi, M.; Lech-Maranda, E.; Oki, Y.; Feldman, T.; Smolewski, P.; Savage, K. J.; Bartlett, N. L.; Walewski, J.; Chen, R.; Ramchandren, R.; Zinzani, P. L.; Cunningham, D.; Rosta, A.; Josephson, N. C.; Song, E.; Sachs, J.; Liu, R.; Jolin, H. A.; Huebner, D.; Radford, J.
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)

多发性骨髓瘤FDG PET/CT的解释标准 (动力): 最终结果。动力 (PET使用的意大利骨髓瘤标准)

European Journal of Nuclear Medicine and Molecular Imaging
IF7.6
2017-12-2187
PREAI
Nanni, Cristina; Versari, Annibale; Chauvie, Stephane; Bertone, Elisa; Bianchi, Andrea; Rensi, Marco; Bello, Marilena; Gallamini, Andrea; Patriarca, Francesca; Gay, Francesca; Gamberi, Barbara; Ghedini, Pietro; Cavo, Michele; Fanti, Stefano; Zamagni, Elena
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study

第一个化疗周期后中期PET的预测作用和对霍奇金淋巴瘤患者ABVD反应的顺序评估-波兰淋巴瘤研究组 (PLRG) 观察性研究

ANNALS OF ONCOLOGY
IF65.4
2017-12-0114
OAAI
Zaucha, J. M.; Malkowski, B.; Chauvie, S.; Subocz, E.; Tajer, J.; Kulikowski, W.; Fijolek-Warszewska, A.; Biggi, A.; Fallanca, F.; Kobylecka, M.; Dziuk, M.; Woszczyk, D.; Rybka, J.; Kroll-Balcerzak, R.; Bergesio, F.; Romanowicz, A.; Chamier-Cieminska, A.; Kurczab, P.; Giza, A.; Lesniewski-Kmak, K.; Zaucha, R.; Swietlik, D.; Wrobel, T.; Knopinska-Posluszny, W.; Walewski, J.; Gallamini, A.

研究方向

暂未获取到该数据
S
Stéphane Chauvie
H 指数:30论文数:216被引数:3.8万
U
Umberto Vitolo
H 指数:76论文数:646被引数:2.1万
P
Pier Luigi Zinzani
H 指数:117论文数:1,841被引数:6.1万
A
Alessandro Rambaldi
H 指数:125论文数:1,473被引数:6.1万
A
Annibale Versari
H 指数:47论文数:337被引数:8,601
A
Alberto Biggi
H 指数:21论文数:81被引数:4,737
J
Jan Maciej Zaucha
H 指数:33论文数:382被引数:4,363
C
Corrado Tarella
H 指数:52论文数:392被引数:1.0万
S
Simonetta Viviani
H 指数:39论文数:207被引数:7,178
M
Michel Meignan
H 指数:62论文数:349被引数:1.8万